Glenn Saldanha of Glenmark appointed IPA President
New Delhi: Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, said Glenn Saldanha has been appointed as President for 2017-19.
Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.
IPA also appointed Panacea Biotec Joint Managing Director Rajesh Jain as Vice President.
The IPA, initially formed by eight national companies in November 1999, has now 20 research-based national pharmaceutical companies in its fold.
Some of the prominent members include Lupin, Cadila Healthcare, Cipla, Dr. Reddy's Laboratories and Sun Pharmaceutical Industries among others.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd